| abstract |
The present invention provides compounds of formula I wherein p, Ar, R 1 , R 2 , R 3 , R a , R b , R c , R d and R e are as defined herein. Or a pharmaceutically acceptable salt, solvate or prodrug thereof. Also provided are pharmaceutical compositions, methods of using and producing the compounds. The compounds are useful for the treatment of diseases associated with monoamine reuptake inhibitors. |